Company: APXIF
Filing Date: 2025-03-31
Form Type: F-4/A
Source: 0001213900-25-026339
Chunk: 312

Company: APx Acquisition Corp. I
Filing Date: 2025-03-31
Form: F-4/A
Chunk 312
---
 2021, by and between SPAC and Continental (the “SPAC Warrant Agreement”), pursuant to which: (i) SPAC will assign to the Company all of SPAC’s rights, interests, and obligations in and under the SPAC Warrant Agreement (as defined herein), and (ii) the SPAC Warrant Agreement will be amended to, inter alia, (a) change all references from “Warrants” (as such term is Warrant Assignment, Assumption and Amendment Agreement) to Company Warrants, (b) change all references from “Ordinary Shares” (as such term is the Warrant Assignment, Assumption and Amendment Agreement) underlying such warrants to Company Shares, and (c) cause each outstanding Company Warrant to represent the right to acquire, from the date on which such Company Warrant becomes exercisable, one whole Company Share. MultiplAI Share Purchase Agreement and Contribution Agreement On March 13, 2024, the Parent, MultiplAI and the MultiplAI Shareholders entered into the MultiplAI Share Purchase Agreement relating to the MultiplAI Acquisition. On August 27, 2024, Parent, MultiplAI and the MultiplAI Shareholders (with APx’s consent) terminated the MultiplAI Share Purchase Agreement. As a result of such termination, we will not acquire MultiplAI, our business will not be combined pursuant to the Business Combination Agreement, and all rights and obligations of MultiplAI under the Business Combination Agreement ceased and terminated, subject to certain exceptions. Among the surviving obligations arising from the MultiplAI SPA Termination Agreement, includes: (a) trading restrictions of SPAC shares, which shall not be made in violation of the restrictions imposed by U.S. federal securities laws and the rules and regulations of the SEC promulgated thereunder; (b) notification of SPAC regarding any shareholder litigation relating to the Business Combination Agreement, as well as permission of participation of SPAC and the Company in the defense and any potential settlements; (c) waiver of any claims against SPAC’s Trust Account before the Merger Effective Time; and (d) confidentiality obligations. No fees or similar compensation upon the termination of the MultiplAI Share Purchase Agreement were paid. 155 Except as set forth above, no other terms of the Business Combination have been modified, and we and APx intend to complete the combination of our businesses (without the acquisition of MultiplAI) as set forth in the Business Combination Agreement. Prior to the Notice